1/29
06:16 am
bdmd
Baird Medical Investment (NASDAQ:BDMD) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Baird Medical Investment (NASDAQ:BDMD) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
1/28
08:30 am
bdmd
Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass
Medium
Report
Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass
1/26
08:30 am
bdmd
Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital
Low
Report
Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital
1/20
08:30 am
bdmd
Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference
Low
Report
Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference
1/7
08:30 am
bdmd
Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam
Low
Report
Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam
12/17
08:30 am
bdmd
Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D
Medium
Report
Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D
12/13
01:10 am
bdmd
Baird Medical Investment (NASDAQ:BDMD) was upgraded by analysts at
Wall
Low
Report
Baird Medical Investment (NASDAQ:BDMD) was upgraded by analysts at
Wall
12/8
08:30 am
bdmd
Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment Capabilities for Leading Arizona Surgeon
Medium
Report
Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment Capabilities for Leading Arizona Surgeon
12/3
08:30 am
bdmd
Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
High
Report
Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion